DOEGenomes.org
Human Genome Project Information  Genomics:GTL  Microbial Genome Program  home
-
skip navigation
Home Site Index Home
What's New
About the HGP Home Ethical, Legal, and Social Issues Home
Research Education Medicine Media
Gene Therapy Gene Therapy Privacy Issues and Other Legislation
Gene Testing Gene Therapy Patenting Issues in Genetics Other Ethical, Legal, and Social Issues
Gene Therapy DNA Forensics Courts and the New Genetics
Gene Therapy
Genetics Privacy and Legislation

 Subject Index

 Send the url of this page to a friend

News
 What's New
 Meetings Calendar
 Media Guide

Basic Information
 FAQs
 Glossary
 Acronyms
 Links
 Genetics 101
 Publications

About the Project
 What is it?
 Goals
 Progress
 History
 Ethical Issues
 Benefits
 Genetics 101

Medicine &
the New Genetics

 Home
 Gene Testing
 Gene Therapy
 Pharmacogenomics

 Disease Information
 Genetic Counseling

Ethical, Legal,
Social Issues

 Home
 Privacy Legislation

 Gene Testing
 Patenting
 Forensics
 Genetically Modified Food
 Behavioral Genetics
 Minorities, Race, Genetics
 Genetics in Courtroom

Education
 Teachers
 Careers
 Students
 Webcasts Audio/Video
 Images
 Videos
 Chromosome Poster
 Presentations
 Genetics 101
 
Genética Websites en Español

Research
 Home
 Sequencing
 Instrumentation
 Mapping
 Bioinformatics
 Functional Genomics
 ELSI Research
 Recent Abstracts
 US,Intl. Research Sites
 Funding

Publications
 Human Genome News
 Chromosome Poster
 Primer Molecular Genetics
 To Know Ourselves
 Your Genes, Your Choices
 List of All Publications

  ???Search This Site


 Contact Us
 Privacy Statement

 Site Stats and Credits

Quick Links for this page:


I.  Federal Policy History

No federal legislation has been passed relating to genetic discrimination in individual insurance coverage or to genetic discrimination in the workplace.  Several bills were introduced during the last decade.  Some of these bills attempted to amend existing civil rights and labor laws, while others stood alone.  The primary public concerns are that (1) insurers will use genetic information to deny, limit, or cancel insurance policies or (2) employers will use genetic information against existing workers or to screen potential employees.  Because DNA samples can be held indefinitely, there is the added threat that samples will be used for purposes other than those for which they were gathered.

Executive Order Protecting Federal Employees
On February 8, 2000, U.S. President Clinton signed an executive order prohibiting every federal department and agency from using genetic information in any hiring or promotion action.  This executive order, endorsed by the American Medical Association, the American College of Medical Genetics, the National Society of Genetic Counselors, and the Genetic Alliance

  • Prohibits federal employers from requiring or requesting genetic tests as a condition of being hired or receiving benefits.  Employers cannot request or require employees to undergo genetic tests in order to evaluate an employee's ability to perform his or her job.

  • Prohibits federal employers from using protected genetic information to classify employees in a manner that deprives them of advancement opportunities.  Employers cannot deny employees promotions or overseas posts because of a genetic predisposition for certain illnesses.

  • Provides strong privacy protections to any genetic information used for medical treatment and research. Under the EO, obtaining or disclosing genetic information about employees or potential employees is prohibited, except when it is necessary to provide medical treatment to employees, ensure workplace health and safety, or provide occupational and health researchers access to data.  In every case where genetic information about employees is obtained, it will be subject to all Federal and state privacy protections.

Bills Introduced to Congress

The following bills have been read and referred to Congressional committees.

  • H.R. 3636 - Genetic Privacy and Nondiscrimination Act of 2003. Introduced to the House of Representatives, November 21, 2003.
  • S. 1053 - Genetic Information Nondiscrimination Act of 2003 - Introduced to the Senate, May 13, 2003.
  • H.R. 1910 - To prohibit discrimination on the basis of genetic information with respect to health insurance. Introduced to the House of Representatives, May 1, 2003.
  • S. 16 - Equal Rights and Equal Dignity for Americans Act of 2003 - To protect the civil rights of all Americans, and for other purposes. Introduced to the Senate, January 7, 2003.
  • Previous Bills (No longer candidates for law)
    • S.1995 - Genetic Information Nondiscrimination Act of 2002.
    • S.318 - Genetic Nondiscrimination in Health Insurance and Employment Act 2001.
    • S. 382 - Genetic Information Nondiscrimination in Health Insurance Act of 2001
    • H.R. 602 - Genetic Nondiscrimination in Health Insurance and Employment Act 2001.

    For more information on federal policy regarding genetic discrimination, see Policy and Legislation: Discrimination from the National Human Genome Research Institute.

Congressional Hearings


II.  State Policy History

States have a patchwork of genetic-information nondiscrimination laws, none of them comprehensive.  Existing state laws differ in coverage, protections afforded, and enforcement schemes.  Some of the first state laws enacted to address this issue prohibited discrimination against individuals with specific genetic traits or disorders.  Other state laws regulate both the use of genetic testing in employment decisions and the disclosure of genetic test results.  These state laws generally prohibit employers from requiring workers and applicants to undergo genetic testing as a condition of employment.  Some states permit genetic testing when it is requested by the worker or applicant for  the purpose of investigating a compensation claim or determining the worker's susceptibility to potentially toxic chemicals in the workplace. These statutes often require the worker to provide informed written consent for such testing, contain specific restrictions governing disclosure, and prevent the employer from taking adverse action against the employee.

[See charts of state genetics laws and information on genetics legislative activity on the National Conference of State Legislatures Web site. See the NIH NHGRI Policy and Legislation Database of all genetics insurance discrimination  legislation.]

State Genetics Reports


III.  Existing Federal Anti-Discrimination Laws and How They Apply to Genetics

Although no specific federal genetic nondiscrimination legislation has been enacted, some believe that parts of existing nondiscrimination laws could be interpreted to include genetic discrimination.  Here is a brief overview of these laws and how they apply to genetics.
 

Americans with Disabilities Act of 1990 (ADA)
The most likely current source of protection against genetic discrimination in the workplace is provided by laws prohibiting discrimination based on disability. Title I of the Americans with Disabilities Act (ADA), enforced by the Equal Employment Opportunity Commission (EEOC), and similar disability-based antidiscrimination laws such as the Rehabilitation Act of 1973 do not explicitly address genetic information, but they provide some protections against disability-related genetic discrimination in the workplace.

  • Prohibits discrimination against a person who is regarded as having a disability.
  • Protects individuals with symptomatic genetic disabilities the same as individuals with other disabilities.
  • Does not protect against discrimination based on unexpressed genetic conditions.
  • Does not protect potential workers from requirements or requests to provide genetic information to their employers after a conditional offer of employment has been extended but before they begin work.   (Note: this is a heightened concern because genetic samples can be stored.)
  • Does not protect workers from requirements to provide medical information that is job related and consistent with business necessity.
In March 1995, the EEOC  issued an interpretation of the ADA.  The guidance, however, is limited in scope and legal effect.  It is policy guidance that does not have the same legal binding effect on a court as a statute or regulation and has not been tested in court.  According to the interpretation,
  • Entities that discriminate on the basis of  genetic predisposition are regarding the individuals as having impairments, and such individuals are covered by the ADA.
  • Unaffected carriers of recessive and X-linked disorders, individuals with late-onset genetic disorders who may be identified through genetic testing or family history as being at high risk of developing the disease are not covered by the ADA

See the ADA Home Page for more information.


Health Insurance Portability and Accountability Act of 1996 (HIPAA)
The Health Insurance Portability and Accountability Act (HIPAA) applies to employer-based and commercially issued group health insurance only.  HIPAA is the only federal law that directly addresses the issue of genetic discrimination.  There is no similar law applying to private individuals seeking health insurance in the individual market.

  • Prohibits group health plans from using any health status-related factor, including genetic information, as a basis for denying or limiting eligibility for coverage or for charging an individual more for coverage.
  • Limits exclusions for preexisting conditions in group health plans to 12 months and prohibits such exclusions if the individual has been covered previously for that condition for 12 months or more.
  • States explicitly that genetic information in the absence of a current diagnosis of illness shall not be considered a preexisting condition.
  • Doesn't prohibit employers from refusing to offer health coverage as part of their benefits packages.

For more information see HIPAA information from US Department of Health and Human Services (HHS) or the HIPAAdvisory Web site.

HIPAA National Standards to Protect Patients' Personal Medical Records, Dec. 2002
This regulation would protect medical records and other personal health information maintained by health care providers, hospitals, health plans and health insurers, and health care clearinghouses. The regulation was mandated when Congress failed to pass comprehensive privacy legislation (as required by HIPAA) by 1999. The new standards: limit the nonconsensual use and release of private health information; give patients new rights to access their medical records and to know who else has accessed them; restrict most disclosure of health information to the minimum needed for the intended purpose; establish new criminal and civil sanctions for improper use or disclosure; and establish new requirements for access to records by researchers and others. They are not specific to genetics, rather they are sweeping regulations governing all personal health information.

For more on the standards, see:


Title VII of the Civil Rights Act of 1964
An argument could be made that genetic discrimination based on racially or ethnically linked genetic disorders constitutes unlawful race or ethnicity discrimination.

  • Protection is available only where an employer engages in discrimination based on a genetic trait that is substantially related to a particular race or ethnic group.
  • A strong relationship between race or national origin has been established for only a few diseases.

IV.  Recommendations for Future Legislation

Workplace Discrimination
Based on previous recommendations from the National Action Plan on Breast Cancer (NAPBC) and the NIH-DOE Working Group on the Ethical, Legal, and Social Implications (ELSI) of human genome research, in a 1998 report the Clinton Administration announced recommendations for future legislation to ensure that discoveries made possible by the Human Genome Project are used to improve health and not to discriminate against workers or their families.  These recommendations are

  • Employers should not require or request that employees or potential employees take a genetic test or provide genetic information as a condition of employment or benefits.
  • Employers should not use genetic information to discriminate against, limit, segregate, or classify employees in a way that would deprive them of employment opportunities.
  • Employers should not obtain or disclose genetic information about employees or potential employees under most circumstances.
Genetic testing and the use of genetic information by employers should be permitted in the following situations to ensure workplace safety and health and to preserve research opportunities. However, in all cases where genetic information about employees is obtained, the information should be maintained in medical files that are kept separate from personnel files, treated as confidential medical records, and protected by applicable state and federal laws.
  • An employer should be permitted to monitor employees for the effects of a particular substance found in the workplace to which continued exposure could cause genetic damage under certain circumstances. Informed consent and assurance of confidentiality should be required. In addition, employers may use the results only to identify and control adverse conditions in the workplace and to take action necessary to prevent significant risk of substantial harm to the employee or others.
  • The statutory authority of a federal agency or contractor to promulgate regulations, enforce workplace safety and health laws, or conduct occupational or other health research should not be limited.
  • An employer should be able to disclose genetic information for research and other purposes with the written, informed consent of the individual.
These recommendations should apply to public and private-sector employers, unions, and labor-management groups that conduct joint apprenticeship and other training programs. Employment agencies and licensing agencies that issue licenses, certificates, and other credentials required to engage in various professions and occupations also should be covered.

Individuals who believe they have been subjected to workplace discrimination based on genetic information should be able to file a charge with the Equal Employment Opportunity Commission, Department of Labor, or other appropriate federal agency for investigation and resolution. The designated agency should be authorized to bring lawsuits in the federal courts to resolve issues that would not settle amicably. The courts should have the authority to halt the violations and order relief, such as hiring, promotion, back pay, and compensatory and punitive damages to the individual. Alternatively, an individual should be able to elect to bring a private lawsuit in federal or state court to obtain the same type of relief plus reasonable costs and attorney's fees. To enforce these protections, the designated enforcement agency must be given sufficient additional resources to investigate and prosecute allegations of discrimination.


Insurance Discrimination

In 1995, the NIH-DOE Joint Working Group on Ethical, Legal, and Social Implications of Human Genome Research (ELSI Working Group) and the National Action Plan on Breast Cancer (NAPBC) developed and published the following recommendations for state and federal policy makers to protect against genetic discrimination (Science, vol. 270, Oct. 20, 1995):

Definitions

  • "Genetic information" is information about genes, gene products, or inherited characteristics that may derive from the individual or a family member.

  • "Insurance provider" means an insurance company, employer, or any other entity providing a plan of health insurance or health benefits, including group and individual health plans whether fully insured or self-funded.

Recommendations
  • Insurance providers should be prohibited from using genetic information or an individual's request for genetic services to deny or limit any coverage or establish eligibility, continuation, enrollment, or contribution requirements.

  • Insurance providers should be prohibited from establishing differential rates or premium payments based on genetic information or an individual's request for genetic services.

  • Insurance providers should be prohibited from requesting or requiring collection or disclosure of genetic information. Insurance providers and other holders of genetic information should be prohibited from releasing genetic information without the individual's prior written authorization. Written authorization should be required for each disclosure and include to whom the disclosure would be made.

A final report of the ELSI Working Group was released in 1996.


Sample Genetic Privacy Act and Commentary

A draft bill (Genetic Privacy Act) was written in 1995 by George Annas of the Boston University School of Public Health to assist legislators. This sample bill proposed that access to information in genetic data banks should be regulated during sample collection, storage, disclosure, and use. Several state lawmakers adapted language and concepts from the draft bill to write proposals for legislation in their own states.


V.  Why Legislation Is Needed Now

(1) Based on genetic information, employers may try to avoid hiring workers they believe are likely to take sick leave, resign, or retire early for health reasons (creating extra costs in recruiting and training new staff), file for workers' compensation, or use healthcare benefits excessively.

(2) Some employers may seek to use genetic tests to discriminate against workers--even those who do not and may never show signs of disease--because the employers fear the cost consequences.

(3) The economic incentive to discriminate based on genetic information is likely to increase as genetic research advances and the costs of genetic testing decrease.

(4) Genetic predisposition or conditions can lead to workplace discrimination, even in cases where workers are healthy and unlikely to develop disease or where the genetic condition has no effect on the ability to perform work

(5) Given the substantial gaps in state and federal protections against employment discrimination based on genetic information, comprehensive federal legislation is needed to ensure that advances in genetic technology and research are used to address the health needs of the nation--and not to deny individuals employment opportunities and benefits. Federal legislation would establish minimum protections that could be supplemented by state laws.

(6) Insurers can still use genetic information in the individual market in decisions about coverage, enrollment, and premiums.

(7) Insurers can still require individuals to take genetic tests.

(8) Individuals are not protected from the disclosure of genetic information to insurers, plan sponsors (employers), and medical information bureaus, without their consent.

(9) Penalties in HIPAA for discrimination and disclosure violations should be strengthened in order to ensure individuals of the protections afforded by the legislation.


VI. Cases of Genetic Discrimination

Although no genetic-employment discrimination case has been brought before U.S. federal or state courts, in 2001 the Equal Employment Opportunity Commission (EEOC) settled the first lawsuit alleging this type of discrimination.

EEOC filed a suit against the Burlington Northern Santa Fe (BNSF) Railroad for secretly testing its employees for a rare genetic condition that causes carpal tunnel syndrome as one of its many symptoms. BNSF claimed that the testing was a way of determining whether the high incidence of repetitive-stress injuries among its employees was work-related. Besides testing for this rare problem, company-paid doctors also were instructed to screen for several other medical conditions such as diabetes and alcoholism. BNSF employees examined by company doctors were not told that they were being genetically tested. One employee who refused testing was threatened with possible termination.

On behalf of BNSF employees, EEOC argued that the tests were unlawful under the Americans with Disabilities Act because they were not job-related, and any condition of employment based on such tests would be cause for illegal discrimination based on disability. The lawsuit was settled quickly with BNSF agreeing to everything sought by EEOC.

Besides the BNSF case, the Council for Responsible Genetics claims that hundreds of genetic-discrimination cases have been documented and describes select cases in its Genetic Discrimination Position Paper (PDF). In one case, genetic testing indicated that a young boy had Fragile X Syndrome, an inherited form of mental retardation. The insurance company for the boy's family dropped his health coverage, claiming the syndrome was a preexisting condition. In another case, a social worker lost her job within a week of mentioning that her mother had died of Huntington's disease and that she had a 50% chance of developing it.

Despite claims of hundreds of genetic-discrimination incidents, an article from the January 2003 issue of the European Journal of Human Genetics reports a real need for a comprehensive investigation of these claims. The article warns that many studies rely on unverified, subjective accounts from individuals who believe they have been unfairly subjected to genetic discrimination by employers or insurance companies. Rarely are these subjective accounts assessed objectively to determine whether actions taken by employers and insurers were truly based on genetic factors or other legitimate concerns.


VII.  More Information

Web Sites

Organizations

Position Statements

Articles

Books

  • Life, Liberty, and the Defense of Dignity: The Challenge for Bioethics by Leon Kass. 313 pp., 2002.

Information on this page was taken from several sources, including the NIH NHGRI Legislation Office in the Office of Policy Coordination, Department of Labor, Human Genome News, National Action Plan on Breast Cancer, and U.S. Department of Energy–National Institutes of Health Working Group on Ethical, Legal, and Social Implications of Genome Research.

Send the url of this page to a friend


To read pdf files, download the free Acrobat Reader software.

Last modified: Tuesday, October 19, 2004

Home * Contacts * Disclaimer

Base URL: www.ornl.gov/hgmis

Office of Science Site sponsored by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research, Human Genome Program